Top-News
Gesundheitswesen: Ausstattung u. Produkte USA

ResMed News

Aktie
WKN:  895878 ISIN:  US7611521078 US-Symbol:  RMD
194,20 €
-2,35 €
-1,20%
12:27:24 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
146,07 Mio.
Marktkapitalisierung *
28,69 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
S&P 500
IR-Website
zur Website
*Stand: 31.07.2023
Weiter abwärts? Short handeln - Jetzt mit Hebel 7,12: ME5SUH

Unternehmensmeldungen

15.03.24 - GlobeNewswire
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
36,000 people across 17 markets responded to the company’s fourth annual survey. 40% of respondents get no more than three nights of good sleep per week. More than one-third ...
09.11.23 - GlobeNewswire
ResMed Adopts New Operating Model to Accelerate Long-term Growth
Justin Leong appointed Chief Product Officer, effective immediately. Katrin Pucknat appointed Chief Marketing Officer, effective immediately. Mike Fliss appointed Chief Revenue ...
05.07.23 - GlobeNewswire
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatment ...
08.06.23 - GlobeNewswire
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-​adherent OSA patients with diastolic and systolic heart failure, ...
25.05.23 - GlobeNewswire
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
France’s Jean-​Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSA ...
02.05.23 - GlobeNewswire
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer
Rider and Haake, both internal promotions, joined ResMed’s executive team on May 1 Rider, currently Senior Vice President, Deputy Global General Counsel will succeed retiring ...
30.03.23 - GlobeNewswire
ResMed Chief Administrative Officer and Global General Counsel to Retire
ResMed to conduct an internal search for a successor general counsel Amy Wakeham appointed Chief Communications and Investor Relations Officer, will join ResMed’s executive ...
13.03.23 - GlobeNewswire
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
81% of respondents experience one or more symptoms indicating poor sleep quality, despite 64% saying they’re satisfied with the quantity of their sleep Women and older ...
26.01.23 - GlobeNewswire
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael ...
22.11.22 - GlobeNewswire
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
-  Acquisition expands ResMed’s SaaS business to Germany, first non-U.S. market
04.09.22 - GlobeNewswire
Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports
New prevalence figure 22–126% higher than previous estimates Prevalence expected to reach 592 million by 2050 Researchers urge global action on smoking cessation and air ...
28.06.22 - GlobeNewswire
ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care
Blaise is a medtech industry thought leader with over 25 years’ experience A board member of MedTech Europe since 2020; President of the Snitem, France’s premier medtech ...
14.06.22 - GlobeNewswire
ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions
Acquisition creates a global leader in out-​of-hospital software solutions Accelerates ResMed’s SaaS strategy by extending ResMed’s position as a leading U.S. provider of SaaS ...
25.05.22 - GlobeNewswire
ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference
SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the ...
18.05.22 - GlobeNewswire
Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study
2–3 hours of nightly PAP use shows health benefits at 3 months, 1 year, and 2 years Health benefits significantly increase by use hour/night, up to 7 hours SAN FRANCISCO, May 18, ...
05.05.22 - GlobeNewswire
ResMed Announces Leadership Change
SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President, Sleep and Respiratory Care, has informed ...
28.04.22 - GlobeNewswire
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022
Year-​over-year revenue grows 12%, operating profit up 5%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at  ...
27.04.22 - GlobeNewswire
ResMed Announces Participation in the 24th Annual Macquarie Australia Conference
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie ...
07.04.22 - GlobeNewswire
ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022
SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of ...
17.03.22 - GlobeNewswire
ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
SAN DIEGO, March 17, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at ...

Newssuche

Videos

newspaper
27.05.24 +4,33%
Technical Trading: Copper Short Chance
Copper Short Typ: Turbo Open End WKN: VQ7PJR Hebel: 9,92 Laufzeit: OpenEnd Einstieg: Market ... Mehr »